openPR Logo
Press release

Burkholderia Infections Market - Global Industry Insights 2024

04-03-2017 09:30 AM CET | Health & Medicine

Press release from: Burkholderia Infections Market

Burkholderia Infections Market - Global Industry Insights 2024

Burkholderia infections are caused by Burkholderia cepacia. It is a gram negative bacillus found in aquatic environment. It is a low virulent bacteria and is a frequent colonizer of fluids used in the hospitals such as IV fluid, irrigation solution etc. B. cepacia can cause health problems to some people such as patients suffering from weakened immune system or chronic lung diseases. Burkholderia infection symptom can vary widely in people, ranging from no symptoms to serious respiratory infection. Based on recent genomic subtyping techniques, Burkholderia infection can be transmitted from person to person. Patients with lung disease such as asthma, CFTR, and COPD are at high risk of suffering from Burkholderia infection. Burkholderia cepacia is resistant to multiple antibiotic such as aminoglycosides, antipseudomonal third-generation cephalosporins and antipseudomonal penicillins.

Global Burkholderia Infections Market Taxonomy

On the basis of drug type, the global market is classified as follows:

-Trimethoprim and sulfamethoxazole

On the basis of distribution channel, the global market is classified as follows:

-Hospital Pharmacies
-Retail Pharmacies and Drug Store

Request a sample copy of this report:

Prevalent Scenarios in Burkholderia infections Market

Increasing prevalence of lung diseases is expected to fuel growth of the Burkholderia infections market. The exact cause for asthma, cystic fibrosis is unknown, though the risk factors can be transferred generation from generation. As per the report of British Lung Foundation, in 2011, an estimated 1.2 million people are living with chronic obstructive pulmonary disease (COPD) and has grown by 27% in the last decade in the U.K. According to the U.S. Cystic Fibrosis Foundation, Europe accounted for the highest number of reported cases of cystic fibrosis in 2012. The growing cases of COPD, asthma and other lung diseases create high risk of burkholderia infection creating an opportunity for manufacturers. Burkholderia infections also cause complications such as soft tissue infections, urinary tract infection and surgical wound infections. It creates an opportunity for the manufacturers to focus on overall treatment. The increasing outbreaks of burkholderia infection has created focus towards the need for proper treatment procedure. Many organization and government policies have included burkholderia infection as one of the severe infections spread from healthcare facilities. Transmission of B. cepacia from contaminated medicines and medical devices. In 2005, CDC notified several states cluster of pneumonia and other infection caused by B. cepacia associated with contaminated mouthwash. In October, 2016, Nurse Assist Inc, recalled its normal saline flush IV syringes due to Burkholderia Cepacia bloodstream infection. FDA identified this as Class I recall, one of the most serious types of recall which may cause serious injuries or death. In 2004, Burkholderia Cepacia was linked to nosocomial infection among Intensive Care Unit patient and was associated with exposure to sublingual probes. The growing concerns related to contaminated medicines and medical devices are expected to create opportunity for product manufacturers in the burkholderia infections market. The effect of B. cepacia on people varies person to person which leaves the infection with no specific treatment. The unavailability of proper treatment creates hindrance to the overall market. North America is expected to account for maximum share of the global burkholderia infections market, owing to the better diagnostic facilities, increasing awareness and government initiative for early diagnosis and treatment of burkholderia infection. Europe is expected to be the second most lucrative burkholderia infections market.

You can also get exclusive discount on this CMI report by clicking on this link:

Burkholderia Infections Market is Highly Fragmented

The market is highly fragmented due to the presence of many emerging players. Major players involved in the burkholderia infections market includes Novabiotics Ltd, iQur Ltd, Aridis Pharmaceuticals LLC, NanoBio Corporation, SUN pharma and others.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Visit Blog:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Burkholderia Infections Market - Global Industry Insights 2024 here

News-ID: 487836 • Views:

More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the